雜志介紹

Drugs雜志介紹

《Drugs》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物，本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為13，最新CiteScore 指數(shù)為22.7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Evolving Trends in Consumption of Direct Oral Anticoagulants in 65 Countries/Regions from 2008 to 2019

  Author: Yan, Vincent K. C.; Li, Hang-Long; Wei, Li; Knapp, Martin R. J.; Wong, Ian C. K.; Chan, Esther W.

• Effectiveness of Nutritional Therapies in Male Factor Infertility Treatment: A Systematic Review and Network Meta-analysis

  Author: Zafar, Mohammad Ishraq; Mills, Kerry E.; Baird, Charles D.; Jiang, Huahua; Li, Honggang

• Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  Author: Blais, Joseph E.; Huang, Xin; Zhao, Jie V.

• The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials

  Author: Pan, Bei; Ge, Long; Lai, Honghao; Hou, Liangying; Tian, Chen; Wang, Qi; Yang, Kelu; Lu, Yao; Zhu, Hongfei; Li, Mengting; Wang, Deren; Li, Xiuxia; Zhang, Yuqing; Gao, Ya; Liu, Ming; Ding, Guowu; Tian, Jinhui; Yang, Kehu

英文介紹

Drugs雜志英文介紹

Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.

Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.

Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.